Galen.ai

Galen.ai mimics real-world data patterns

Galen.ai is revolutionizing biotechnology and healthcare by shifting from observation-based methods to engineering-driven approaches. In biotech, this shift primarily affects drug discovery, genomics, and synthetic biology, with the goal of reducing costs—approximately $2.6 billion per drug—and shortening development timelines from 10 to 15 years. In healthcare, AI enhances clinical trials, diagnostics, and personalized treatment options. GalenKi is at the forefront of applying artificial intelligence to drug development, offering innovative tools for researchers and pharmaceutical companies. Our focus on innovation delivers real-time insights that advance stem cell therapy, gene therapy, oncology, diabetes, and cardiovascular research. Committed to improving healthcare outcomes, our multidisciplinary team optimizes research resources and delivers comprehensive, AI-powered solutions, setting new industry benchmarks.

Ki-galen.ai

GalenKi is at the forefront of applying artificial intelligence to drug development, offering innovative tools for researchers and pharmaceutical companies. Our focus on innovation delivers real-time insights that advance stem cell therapy, gene therapy, oncology, diabetes, and cardiovascular research. Committed to improving healthcare outcomes, our multidisciplinary team optimizes research resources and delivers comprehensive, AI-powered solutions, setting new industry benchmarks.

Galen, AI's Main Biotech Research Areas (By Discipline)

Oncology & Immunotherapy: The leading investment sector, focused on antibody-drug conjugates (ADCs), CAR-T cell therapies, and bispecific antibodies.

Neurology/Neuroscience: Focuses on neurodegenerative diseases and neurodevelopmental disorders, aiming to modulate neural activity.

Genetic Engineering & Gene Therapy: Involves developing CRISPR-based therapies, notably using CRISPR-Cas3 for targeted pathogen eradication.

Artificial Intelligence (AI) in Drug Discovery: Uses AI to analyze biological data to design new drugs.

• mRNA and Protein Engineering: Focuses on developing therapeutics for vaccines and chronic illnesses.

• Regenerative Medicine: Encompasses stem cell research and tissue engineering.